Literature DB >> 18981561

Comparison of the mechanisms of cataract development involving differences in Ca2+ regulation in lenses among three hereditary cataract model rats.

Noriaki Nagai1, Yoshimasa Ito, Noriko Takeuchi, Shigeyuki Usui, Kazuyuki Hirano.   

Abstract

We previously found that the increases in Ca2+ content in the lenses of three hereditary cataract model rats, UPL rat (UPLR), Shumiya cataract rat (SCR) and Ihara cataract rat (ICR), are inhibited by aminoguanidine, a selective inhibitor of inducible nitric oxide synthase, and that the mechanisms of Ca2+ enhancement in these rat models differ. In this study, we compare the mechanisms for dysfunction in Ca2+ regulation in UPLR, SCR and ICR. Decreases in the activity of Ca2+-ATPase were found in the lenses of SCR and ICR concurrent with cataract development. In contrast, the Ca2+-ATPase activity in UPLR with opaque lenses was higher than in those with transparent lenses. On the other hand, ATP levels were markedly decreased in UPLR with opaque lenses. The expression of cytochrome c oxidase (CCO)-1 mRNA and CCO activity in UPLR lenses was found to decrease during cataract development. The nitric oxide (NO) and lipid peroxide levels were also increased in the lenses of UPLR, SCR and ICR with opaque lenses. In UPLR, excessive NO may cause damage to the mitochondrial genome, resulting in a decrease in ATP production and increase in Ca2+-ATPase activity. The decrease in ATP content may cause the decrease in Ca2+-ATPase function resulting in the elevation in lens Ca2+. In SCR and ICR, excessive NO may cause an enhancement of lipid peroxidation resulting in the oxidative inhibition of Ca2+-ATPase. The decrease in Ca2+-ATPase activity may cause the elevation in the level of lens Ca2+, thus leading to lens opacification. Our findings show that the Ca2+ contents in the cataractous lenses of all three model rats are increased, the mechanisms for this Ca2+ enhancement is different in each rat model.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18981561     DOI: 10.1248/bpb.31.1990

Source DB:  PubMed          Journal:  Biol Pharm Bull        ISSN: 0918-6158            Impact factor:   2.233


  5 in total

1.  Spermidine delays eye lens opacification in vitro by suppressing transglutaminase-catalyzed crystallin cross-linking.

Authors:  Alessandro Lentini; Claudio Tabolacci; Palma Mattioli; Bruno Provenzano; Simone Beninati
Journal:  Protein J       Date:  2011-02       Impact factor: 2.371

2.  A mutation in the start codon of γ-crystallin D leads to nuclear cataracts in the Dahl SS/Jr-Ctr strain.

Authors:  Ashley C Johnson; Jonathan W Lee; Ashlyn C Harmon; Zaliya Morris; Xuexiang Wang; Jonathan Fratkin; John P Rapp; Elise Gomez-Sanchez; Michael R Garrett
Journal:  Mamm Genome       Date:  2013-02-13       Impact factor: 2.957

3.  The Intravitreal Injection of Lanosterol Nanoparticles Rescues Lens Structure Collapse at an Early Stage in Shumiya Cataract Rats.

Authors:  Noriaki Nagai; Yuya Fukuoka; Kanta Sato; Hiroko Otake; Atsushi Taga; Mikako Oka; Noriko Hiramatsu; Naoki Yamamoto
Journal:  Int J Mol Sci       Date:  2020-02-05       Impact factor: 5.923

4.  Combination of Lanosterol and Nilvadipine Nanosuspensions Rescues Lens Opacification in Selenite-Induced Cataractic Rats.

Authors:  Saori Deguchi; Reita Kadowaki; Hiroko Otake; Atsushi Taga; Yosuke Nakazawa; Manju Misra; Naoki Yamamoto; Hiroshi Sasaki; Noriaki Nagai
Journal:  Pharmaceutics       Date:  2022-07-21       Impact factor: 6.525

5.  Instillation of Ophthalmic Formulation Containing Nilvadipine Nanocrystals Attenuates Lens Opacification in Shumiya Cataract Rats.

Authors:  Ryoka Goto; Shigehiro Yamada; Hiroko Otake; Yosuke Nakazawa; Mikako Oka; Naoki Yamamoto; Hiroshi Sasaki; Noriaki Nagai
Journal:  Pharmaceutics       Date:  2021-11-25       Impact factor: 6.321

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.